EUPRAXIA PHARMACEUTICALS INC. Pre-Opening Costs
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Pre-Opening Costs of $1.60 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreOpeningCosts · last filed 2026-03-13
| Period end | Pre-Opening Costs 12 month |
|---|---|
| 2025-12-31 | $1.60M 40-F · filed 2026-03-13 |
| 2024-12-31 | $1.57M 40-F · filed 2026-03-13 |
| 2023-12-31 | $404.07K 40-F · filed 2025-03-20 |
| 2022-12-31 | $214.26K 40-F · filed 2024-04-01 |